Literature DB >> 30269877

Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.

Lucy K Smith1, Ashna D Hindori-Mohangoo2, Marie Delnord3, Mélanie Durox3, Katarzyna Szamotulska4, Alison Macfarlane5, Sophie Alexander6, Henrique Barros7, Mika Gissler8, Béatrice Blondel3, Jennifer Zeitlin3.   

Abstract

BACKGROUND: International comparisons of stillbirth allow assessment of variations in clinical practice to reduce mortality. Currently, such comparisons include only stillbirths from 28 or more completed weeks of gestational age, which underestimates the true burden of stillbirth. With increased registration of early stillbirths in high-income countries, we assessed the reliability of including stillbirths before 28 completed weeks in such comparisons.
METHODS: In this population-based study, we used national cohort data from 19 European countries participating in the Euro-Peristat project on livebirths and stillbirths from 22 completed weeks of gestation in 2004, 2010, and 2015. We excluded countries without national data for stillbirths by gestational age in these periods, or where data available were not comparable between 2004 and 2015. We also excluded those countries with fewer than 10 000 births per year because the proportion of stillbirths at 22 weeks to less than 28 weeks of gestation is small. We calculated pooled stillbirth rates using a random-effects model and changes in rates between 2004 and 2015 using risk ratios (RR) by gestational age and country.
FINDINGS: Stillbirths at 22 weeks to less than 28 weeks of gestation accounted for 32% of all stillbirths in 2015. The pooled stillbirth rate at 24 weeks to less than 28 weeks declined from 0·97 to 0·70 per 1000 births from 2004 to 2015, a reduction of 25% (RR 0·75, 95% CI 0·65-0·85). The pooled stillbirth rate at 22 weeks to less than 24 weeks of gestation in 2015 was 0·53 per 1000 births and did not significantly changed over time (RR 0·97, 95% CI 0·80-1·16) although changes varied widely between countries (RRs 0·62-2·09). Wide variation in the percentage of all births occurring at 22 weeks to less than 24 weeks of gestation suggest international differences in ascertainment.
INTERPRETATION: Present definitions used for international comparisons exclude a third of stillbirths. International consistency of reporting stillbirths at 24 weeks to less than 28 weeks suggests these deaths should be included in routinely reported comparisons. This addition would have a major impact, acknowledging the burden of perinatal death to families, and making international assessments more informative for clinical practice and policy. Ascertainment of fetal deaths at 22 weeks to less than 24 weeks should be stabilised so that all stillbirths from 22 completed weeks of gestation onwards can be reliably compared. FUNDING: EU Union under the framework of the Health Programme and the Bridge Health Project.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30269877     DOI: 10.1016/S0140-6736(18)31651-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  A retrospective autopsy study of 42 cases of stillbirth in Avicenna Research Institute.

Authors:  Haleh Soltanghoraee; Maziar Moradi-Lakeh; Narjes Khalili; Azadeh Soltani
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-23       Impact factor: 3.105

2.  Converging or diverging trajectories of mortality under one year of age in the Baltic States: a comparison with the European Union.

Authors:  Agnieszka Genowska; Birute Strukcinskiene; Anita Villerusa; Jerzy Konstantynowicz
Journal:  Arch Public Health       Date:  2021-05-13

Review 3.  Data-Driven Modeling of Pregnancy-Related Complications.

Authors:  Camilo Espinosa; Martin Becker; Ivana Marić; Ronald J Wong; Gary M Shaw; Brice Gaudilliere; Nima Aghaeepour; David K Stevenson
Journal:  Trends Mol Med       Date:  2021-02-08       Impact factor: 15.272

4.  Decreasing trend in preterm birth and perinatal mortality, do disparities also decline?

Authors:  Anita C J Ravelli; Martine Eskes; Joris A M van der Post; Ameen Abu-Hanna; Christianne J M de Groot
Journal:  BMC Public Health       Date:  2020-05-26       Impact factor: 3.295

5.  Comparing regional neonatal mortality rates: the influence of registration of births as live born for birth weight <500 g in Taiwan.

Authors:  Liang-Yi Wang; Yu-Shan Chang; Fu-Wen Liang; Yung-Chieh Lin; Yuh-Jyh Lin; Tsung-Hsueh Lu; Chyi-Her Lin
Journal:  BMJ Paediatr Open       Date:  2019-07-22

6.  Pregnancy outcomes in facility deliveries in Kenya and Uganda: A large cross-sectional analysis of maternity registers illuminating opportunities for mortality prevention.

Authors:  Peter Waiswa; Brennan V Higgins; Paul Mubiri; Leah Kirumbi; Elizabeth Butrick; Rikita Merai; Nancy L Sloan; Dilys Walker
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

7.  Impact of macro-socioeconomic determinants on sustainable perinatal health care in Portugal: a qualitative study on the opinion of healthcare professionals and experts.

Authors:  Julia Nadine Doetsch; Sandra C S Marques; Thomas Krafft; Henrique Barros
Journal:  BMC Public Health       Date:  2021-01-25       Impact factor: 3.295

8.  Management and outcomes of extreme preterm birth.

Authors:  Andrei S Morgan; Marina Mendonça; Nicole Thiele; Anna L David
Journal:  BMJ       Date:  2022-01-10

9.  Producing valid statistics when legislation, culture and medical practices differ for births at or before the threshold of survival: report of a European workshop.

Authors:  L K Smith; B Blondel; J Zeitlin
Journal:  BJOG       Date:  2019-11-06       Impact factor: 6.531

10.  Stillbirth is associated with increased risk of long-term maternal renal disease: a nationwide cohort study.

Authors:  Peter M Barrett; Fergus P McCarthy; Marie Evans; Marius Kublickas; Ivan J Perry; Peter Stenvinkel; Ali S Khashan; Karolina Kublickiene
Journal:  Am J Obstet Gynecol       Date:  2020-02-26       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.